Phosphoinositide 3-kinase (PI3K); cyclin dependent kinase 4 (CDK4); Bruton's tyrosine kinase (BTK) BriefCommunication Pages: 982 - 982
Factor Xa; thrombin (factor IIa; F2); factor IXa; factor VIIa/tissue factor complex BriefCommunication Pages: 987 - 987
Helicobacter pylori γ-glutamyl transpeptidase (ggt); H. pylori vacuolating cytotoxin (vacA) BriefCommunication Pages: 990 - 990
Prostaglandin D2 receptor subtype DP1 (PTGDR1; DP1); superoxide dismutase 1 (SOD1) BriefCommunication Pages: 991 - 991
High-coverage, single-cell genome and exome sequencing at base-pair resolution to aid biomarker identification BriefCommunication Pages: 993 - 993
Single immunoglobulin and toll-interleukin 1 receptor domain ( Sigirr ; Tir8 )-deficient mouse model of Campylobacter jejuni infection BriefCommunication Pages: 994 - 994
Targeting glioma stem-like cells (GSCs) with CpG-siRNA conjugates BriefCommunication Pages: 995 - 995
Chimeric antigen receptor (CAR)-specific invariant NK T (iNKT) cell therapy BriefCommunication Pages: 996 - 996
Oncolytic virus to enhance efficacy of chimeric antigen receptor (CAR)-specific T cells BriefCommunication Pages: 997 - 997
X-ray crystal structures of thiol-reactive agents in complex with Mycobacterium tuberculosis secreted antigen 85-C (fbpC; ag85C) BriefCommunication Pages: 998 - 998
Integrated genomic and proteomic analysis of cancer cells to prioritize the study of cancer drivers BriefCommunication Pages: 999 - 999
RAC1 P29S as a marker of resistance to BRAF inhibitors in melanoma BriefCommunication Pages: 1000 - 1000